Search Results

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic

Tobin How to Build Breakthrough GPCR Programs <p class="font_8">Watch Now</p> Terry Hebert GPCR Signaling ">Watch Now</p> Terry Kenakin The New Frontier of GPCR Therapeutics 1 2 3 1 ... 1 2 3 ... 3 The scientists GPCR and the offered resources in my work sphere GPCR researcher Thank you for bringing this course with GPCR researcher About the GPCR Masterclass What is a GPCR Masterclass? The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

GPCR ecosystem. , the choice of immunogen has already determined whether a GPCR antibody can succeed. - Ball and Lin on the power of scientific communication 39:40 The GPCR therapeutic market and what remains GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Whether a 20% reduction in beta-arrestin coupling matters therapeutically depends on the cell type, the drug response differences, and a largely unexplored opportunity in existing drug pipelines Antibody therapeutics Antibody therapeutics for GPCRs: the pipeline argument Biologics have a substantially higher success The combination of those two facts, Gilchrist argues, makes antibody-based GPCR therapeutics an underexplored The precedent of drugging a receptor without knowing what activates it naturally, and getting therapeutic

therapeutic target in atherosclerosis - and is candid about what happens when organizational priorities His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Your One-Stop-Shop for GPCR Drug Discovery and Development Researchers developing GPCR-targeted therapeutics solutions including cell-based assays for basic research through therapeutic discovery and development Principle of Eurofins DiscoverX Cell-based Assays Whether you are developing small-molecule or biologic therapeutic Explore GLP-1 Product Solutions to Support Obesity/Diabetes See GLP-1 Solutions Accelerating Obesity Therapeutics Eurofins Discovery GPCR services provides the industry's most extensive collection of validated GPCR

Built for the GPCR community, by the GPCR community. GPCR event? Welcome. global community of GPCR scientists — all in one place. Each session explores mechanistic models, translational challenges, and real-world therapeutic implications Do I need prior knowledge of GPCR pharmacology?

into industry, and his role leading and shaping multidisciplinary teams for screening and innovative therapeutics How advanced assay design is essential for translating cell-based GPCR signals to therapeutic outcomes Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic Marro’s career advanced through roles at Novartis and Tectonic Therapeutic, contributing to projects across key therapeutic areas—spanning metabolic, cardiovascular, and gastrointestinal diseases.

therapeutic landscape of bitter taste receptors, and the importance of data-driven resources. GPCR Premium. efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel therapeutic GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Michelle Halls reveals how organized GPCR signaling drives assay innovation and new therapeutic insights concentrations, her work highlights why receptor localization and protein complex assembly matter for therapeutic localized signaling events, how these mechanisms are hijacked in disease, and how they can be leveraged for therapeutic GPCR Premium . GPCR Podcast? Leave a Review.

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics research career The inside story behind founding Blue Therapeutics and targeting supraspinal pain pathway Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. as therapeutic targets. He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general GPCR Podcast? Leave a Review.

GPCR Ecosystem. Research GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry therapeutics. GPCR. accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic

structures routine, the insight that seeded Heptares Therapeutics. She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

activation, and resistant to pharmacological blockade - and why those properties have shaped both the therapeutic , then a Cornell postdoc 08:03 - Choosing taste GPCRs as a research focus - how the arrival of GPCR structures GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

GPCR webinars are live online scientific sessions focused on G protein-coupled receptor (GPCR) biology Each session explores mechanistic models, translational challenges, and real-world therapeutic implications GPCR platform. Do I need prior knowledge of GPCR pharmacology? Are these GPCR webinars free? Yes. All live GPCR webinars are free to attend. GPCR Ecosystem as a free member.

GPCR podcast. << Back to podcast list Strategic Partner(s) Signals, pH, and Discovery : Cracking GPCR Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy , and how understanding receptor activity in acidic micro environments could unlock new therapeutic strategies GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

build a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR a basis for understanding aGPCR biology in the nervous system. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

<< Back to podcast list Strategic Partner(s) Exploring Career Paths in GPCR Research with Dr. Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

Hebert's argument — that challenge trials depend on a reliable therapeutic the field did not yet have Challenge trials and the therapeutic floor — Why the ethics of accelerating vaccine trials depend on challenge trial — where volunteers receive placebo or active virus — is ethically unworkable without a therapeutic Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University GPCR Podcast? Leave a Review.

company supporting pharmaceutical, life science, and academic scientists in the development of new therapeutics analysis of drug action and is known for applying binding kinetics to the development of effective therapeutics , particularly GPCR antagonists. GPCR Member ResearchGate Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

, and serves as Deputy Director of the Australian Research Council Centre for Personalised Therapeutics Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.

the company's ability to predict the residence time of a ligand and its potential correlation with a therapeutic Therapeutic Effect and Receptor Interactions Aurelien Rizk and Yamina had a detailed discussion about the importance of gaining more information about the therapeutic effect in patients or animals and the They also shared their preference for small molecule therapies over protein therapeutics. GPCR Podcast? Leave a Review.

Turn GPCR discovery chaos into clarity—Yamina’s Corner offers expert GPCR strategy, CRO guidance, and Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic Abishek Iyer, CEO Ashta Therapeutics Before working with Yamina, we had solid internal momentum but needed GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr. GPCR Corp Proudly created with Wix.com

bases for ligand binding and efficacy to help optimize the design and engineering of more efficacious therapeutics perspective in the pursuit of receptor subtype-specific ligands, a major aspect to achieve safer, on-target therapeutics The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and A notable therapeutic is an enzyme that hydrolyzes cocaine. as a treatment for cocaine abuse, a debilitating disease that would require long-term and sustained therapeutic

I then started my career at Evotec before moving to Domain Therapeutics (called Faust pharmaceutical chemistry. 6 years ago I decided to take on a new challenge by taking the position of CSO at Confo Therapeutics Christel Menet on the web Hyphen Projects GPCRS Drug Discovery Confo Therapeutics LinkedIn Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

Terry Hebert is a Professor of Pharmacology and Therapeutics at McGill University. The goal is to test therapeutic strategies targeting the AT1R, alpha-adrenergic, and beta-adrenergic Drugging GPCRs on the Nuclear Membrane GPCRs are not confined to the cell surface. Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.

He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic GPCR Unlock the Full Dr. GPCR Podcast? Leave a Review.

Class C GPCRs are structural and mechanistic outliers within the GPCR superfamily. mutations in the GABA-B transmembrane domain and what they suggest about precision pharmacology The therapeutic But its therapeutic window is narrow. GPCR Ecosystem Unlock the Full Dr. GPCR Podcast? Leave a Review.